¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-1ÀÏ : 2024-03-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-1ÀÏ : 2024-03-28
±³À°ÀÏÀÚ : 2024-03-28
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-1ÀÏ

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í 2¿ù 28ÀϱîÁö  ȸ¿ø 100,000¿ø / ºñȸ¿ø 200,000¿ø3¿ù 1ÀϺÎÅÍ    ȸ¿ø  200,000¿ø / ºñȸ¿ø 300,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 09:00~09:25 Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim(Sungkyunkwan University Korea)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 09:25~09:50 Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai(St. Marianna University Japan)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 09:50~10:15 NK lymphoma genomics Weili Zhao(Shanghai Jiao Tong University China)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 10:30~11:15 Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell(Wellcome Sanger Institute UK)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 11:15~12:00 Lab-on-a-chip in hematology Chong H. Ahn(University of Cincinnati USA)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 12:15~13:05 The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH(  paroxysmal nocturnal hemoglobinuria) Sung-hyun Kim(Dong-A University Korea)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 13:50~15:20 Prognostic value of end-of-treatment [18F]FDG PET/CT in newly diagnosed patients with primary central nervous system lymphoma who respond to first-line treatment with high-dose methotrexate-based regimen Hyungwoo Cho(University of Ulsan Korea)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 15:30~15:55 Approaches to treat people with hemophilia: What¡¯s new and what¡¯s not? Leonard Valentino(The National Bleeding Disorders Foundation USA)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 15:55~16:20 Prospects and challenges of gene therapy Alok Srivastava(Christian Medical College India)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 16:20~16:45 Exploring personalized tailored hemophilia treatment Jeong-A Park(Inha University Korea)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 16:55~17:25 Molecular alterations and clinical implications in MDS(myelodysplastic syndrome) Yasushi Miyazaki(Nagasaki University Japan)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 17:25~17:55 Recent advances and future therapeutic strategies in MDS((myelodysplastic syndrome) Garcia-Manero Guillermo(The University of Texas USA)

±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 17:55~18:20 Current diagnostic challenges of MDS(myelodysplastic syndrome) In-Suk Kim(Pusan National University Korea)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-1ÀÏ : 2024-03-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ °æÀÎÁöȸ Çмúȸ : 2024-03-28
´ÙÀ½±Û (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¾Ë·¹¸£±â ºñ¿°¿¡¼­ ¹Ì»ý¹° ±ºÁýÀÇ ¿ªÇÒ : 2024-03-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20700 ºÎ»ê Çѱ¹¿©ÀÚÀÇ»çȸ ºÎ»êÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö : 2024-05-28 1 12 2024-05-25
20699 ´ëÀü Á¦ 4ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ÃæûÁöȸ ¿¬¼ö°­Á : 2024-05-26 0 34 2024-05-25
20698 ¼­¿ï 2024³â ´ëÇѳëÀκ´ÇÐȸ Á¦73Â÷ Çмú´ëȸ(Ãá°è)(2ÀÏÂ÷) : 2024-05-26 0 9 2024-05-25
20697 ¼­¿ï (¿Â¶óÀÎ) 2024³â ±âº» ¼Ò¾Æ ÀÀ±Þ óġ ±³À°°úÁ¤ 1Â÷(BPECC) : 2024-05-26 0 4 2024-05-25
20696 Ãæ³² Á¦ 28ȸ ¼øõÇâ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¿ò(2ÀÏÂ÷) : 2024-05-26 0 6 2024-05-25
20695 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_1ÀÏÂ÷) : 2024-05-26 0 3 2024-05-25
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 105 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 55 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 66 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 77 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 64 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 79 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 48 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 31 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 63 2024-05-11
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷